Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
- Status
- COMPLETED
- Phase
- PHASE2
MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2